logo

HomeArticlesServicePriceAbout

EN

Menu

Home
Articles
Search
About
EN
logo
Price
logo

Company

AboutTerms of Service Privacy Policy

Social

LinkedIn Twitter Discord

Contact

contact@coresixteen.com coresixteen.com
Company NameCORE16 Inc.
CEODavid Cho
Business Registration Number762-81-03235
Address83, Uisadang-daero, Yeongdeungpo-gu, Seoul, 07325, Republic of KOREA
Sempra
Search Result
Firm
user
셀스마트 대니
·
3 months ago
0
0
📉 S&P 500 Stocks with Over 10% Target Price Downgrade in the 4th Week of March (BF.B, SRE, TER, TFX, ULTA)
article
Strong Sell
Strong Sell
SRE
Sempra
+4
user
셀스마트 대니
·
3 months ago
0
0
📉 S&P 500 Stocks with Over 10% Target Price Downgrade in the 4th Week of March (BF.B, SRE, TER, TFX, ULTA)
Over the past four weeks (from Feb 21 to Mar 21, 2025), analyst reports indicate that several major S&P 500 companies have had their target prices downgraded by more than 10%.This reflects a combination of changes in company fundamentals, macroeconomic conditions, and shifts in industry competitiveness. From a sell-side perspective, these downward revisions may imply short-term price pressure, making it important for investors to consider appropriate risk management and sell strategies.Below is a summary of companies whose target prices were revised down by more than 10% over the past four weeks. For each company, we include the target price as of Feb 21 and Mar 21, 2025, along with the percentage decrease.1. Brown Forman Class B (BF.B-US)Target Price (Mar 21, 2025): $40Target Price (Feb 21, 2025): $46Change: -13.0%Key Issue: Consumer spending slowdown and rising raw material costs are squeezing margins. Heightened competition in the global alcoholic beverage market is also limiting growth prospects.2. Sempra (SRE-US)Target Price (Mar 21, 2025): $83Target Price (Feb 21, 2025): $94Change: -11.7%Key Issue: Volatility in the energy and utility markets, along with regulatory shifts, are weighing on the company’s earnings outlook.3. Teradyne (TER-US)Target Price (Mar 21, 2025): $116Target Price (Feb 21, 2025): $136Change: -14.7%Key Issue: Softening demand and rising competition in the semiconductor and automation test equipment markets are dampening growth potential.4. Teleflex (TFX-US)Target Price (Mar 21, 2025): $165Target Price (Feb 21, 2025): $240Change: -31.3%Key Issue: Weaker demand in the medical device market and global economic uncertainty are dragging down performance expectations.5. Ulta Beauty (ULTA-US)Target Price (Mar 21, 2025): $412Target Price (Feb 21, 2025): $461Change: -10.6%Key Issue: Concerns over consumer demand and increased competition are constraining growth, while shifting beauty trends are creating uncertainty in sales projections.While the reasons and degrees of target price revisions vary by company, most reflect common macroeconomic risks such as recession concerns, supply chain issues, rising costs, and intensified competition. In some cases, industry-specific structural changes (e.g., EV battery demand, semiconductor cycles) have also played a significant role.From a sell-side strategy perspective, these downgraded stocks are likely to experience near-term downward momentum. Investors may consider reducing portfolio exposure or adopting short strategies for risk control. Notably, upcoming earnings reports, interest rate changes, and macroeconomic data could significantly heighten volatility, so a flexible and responsive approach is essential.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.
article
Strong Sell
Strong Sell
SRE
Sempra
+4
Event
user
셀스마트 대니
·
4 months ago
0
0
S&P 500 Stocks with Over 10% Target Price Downgrades – Part 1 📉 (3rd Week of March)
article
Strong Sell
Strong Sell
SRE
Sempra
+5
user
셀스마트 대니
·
4 months ago
0
0
S&P 500 Stocks with Over 10% Target Price Downgrades – Part 1 📉 (3rd Week of March)
Over the past four weeks (Feb 24, 2025 – Mar 12, 2025), several major S&P 500 companies have seen their target prices cut by more than 10% in analyst reports.This reflects a combination of fundamental shifts in these companies, macroeconomic factors, and changes in industry competition. From a sell-side perspective, such target price downgrades can signal short-term downward pressure on stock prices, requiring investors to consider appropriate risk management and sell strategies.Below is a list of stocks whose target prices have been cut by more than 10% compared to four weeks ago. For each stock, we provide the target price as of February 24, 2025, and March 12, 2025, along with the percentage decrease.1. Builders FirstSource (BLDR-US)Target Price (Mar 12, 2025): $178Target Price (Feb 14, 2025): $198Decline: -10.1%Key Issue: The construction sector slowdown and rising raw material costs are weighing on the company's profitability.2. Celanese (CE-US)Target Price (Mar 12, 2025): $69Target Price (Feb 14, 2025): $91Decline: -24.2%Key Issue: Weakening demand for chemical products and increased raw material costs are negatively impacting earnings forecasts.3. Hewlett Packard Enterprise (HPE-US)Target Price (Mar 12, 2025): $20Target Price (Feb 14, 2025): $24Decline: -16.7%Key Issue: Slowing demand for IT infrastructure and weaker data center growth are the main reasons for the downward revision.4. Moderna (MRNA-US)Target Price (Mar 12, 2025): $53Target Price (Feb 14, 2025): $63Decline: -15.9%Key Issue: Declining Covid-19 vaccine demand and uncertainty around its drug pipeline have heightened investor concerns.5. Sempra (SRE-US)Target Price (Mar 12, 2025): $83Target Price (Feb 14, 2025): $94Decline: -11.7%Key Issue: Increased volatility in the energy and utilities markets has raised concerns about the company's profitability.6. Teleflex (TFX-US)Target Price (Mar 12, 2025): $165Target Price (Feb 14, 2025): $240Decline: -31.3%Key Issue: Slowing demand in the medical device market and increasing competition are driving lower earnings forecasts.While the reasons and extent of target price downgrades vary by company, overall, these revisions reflect common macroeconomic risks, such as economic recession fears, supply chain uncertainties, rising costs, intensifying competition.Additionally, some companies are affected by structural industry changes, such as fluctuations in EV battery demand and semiconductor industry trends.From a sell-side perspective, stocks experiencing significant target price cuts could face short-term downside pressure. Investors should consider risk management strategies, including portfolio rebalancing, short positions, market-driven adjustments – Stay alert to upcoming earnings reports, interest rate changes, and key economic indicators, as these can significantly impact volatility.By aligning investment decisions with broader market trends, investors can navigate these shifts with greater flexibility and strategic foresight.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.
article
Strong Sell
Strong Sell
SRE
Sempra
+5
user
셀스마트 대니
·
4 months ago
0
0
S&P 500 Stocks with Over 10% Target Price Downgrades – Part 2 📉 (3rd Week of March)
article
Strong Sell
Strong Sell
AMD
Advanced Micro Devices
+26
user
셀스마트 대니
·
4 months ago
0
0
S&P 500 Stocks with Over 10% Target Price Downgrades – Part 2 📉 (3rd Week of March)
Over the past eight weeks (Jan 17, 2025 – Mar 12, 2025), several major S&P 500 companies have seen their target prices cut by more than 10% in analyst reports.This reflects a combination of fundamental shifts in these companies, macroeconomic factors, and changes in industry competition. From a sell-side perspective, such target price downgrades can signal short-term downward pressure on stock prices, requiring investors to consider appropriate risk management and sell strategies.Below is a list of stocks whose target prices have been cut by more than 10% compared to eight weeks ago. For each stock, we provide the target price as of January 17, 2025, and March 12, 2025, along with the percentage decrease.1. AES (AES-US)Target Price (Mar 12, 2025): $15Target Price (Jan 17, 2025): $18Decline: -16.7%Key Issue: Slower growth in the power and utilities sector, combined with rising energy costs, is pressuring the company’s profitability.2. Albemarle (ALB-US)Target Price (Mar 12, 2025): $98Target Price (Jan 17, 2025): $112Decline: -12.5%Key Issue: Falling lithium prices and declining global EV demand are negatively impacting the company’s earnings outlook.3. Advanced Micro Devices (AMD-US)Target Price (Mar 12, 2025): $147Target Price (Jan 17, 2025): $173Decline: -15.0%Key Issue: Slowing demand in the data center and PC markets, along with intensified AI competition, has led to downward earnings revisions.4. Biogen (BIIB-US)Target Price (Mar 12, 2025): $198Target Price (Jan 17, 2025): $228Decline: -13.2%Key Issue: Delays in new drug approvals and growing competition are raising concerns about the company’s revenue growth.5. Builders FirstSource (BLDR-US)Target Price (Mar 12, 2025): $178Target Price (Jan 17, 2025): $203Decline: -12.3%Key Issue: A slowdown in the construction industry and rising raw material costs are putting pressure on profitability.6. Celanese (CE-US)Target Price (Mar 12, 2025): $69Target Price (Jan 17, 2025): $93Decline: -25.8%Key Issue: Weakening demand for chemical products and rising raw material costs are negatively affecting earnings.7. Charles River Laboratories (CRL-US)Target Price (Mar 12, 2025): $183Target Price (Jan 17, 2025): $204Decline: -10.3%Key Issue: Increased competition in the pharmaceutical research and lab supply market is putting pressure on growth projections.8. Electronic Arts (EA-US)Target Price (Mar 12, 2025): $144Target Price (Jan 17, 2025): $163Decline: -11.7%Key Issue: Increased competition in the gaming industry and weaker-than-expected demand for new releases are weighing on revenue forecasts.9. Edison International (EIX-US)Target Price (Mar 12, 2025): $71Target Price (Jan 17, 2025): $86Decline: -17.4%Key Issue: Profitability concerns in the utilities sector and growing regulatory pressures have led to a target price reduction.10. Enphase Energy (ENPH-US)Target Price (Mar 12, 2025): $78Target Price (Jan 17, 2025): $89Decline: -12.4%Key Issue: Slower growth in the renewable energy market and rising raw material costs are weighing on the company’s performance.11. Fidelity National Information Services (FIS-US)Target Price (Mar 12, 2025): $83Target Price (Jan 17, 2025): $93Decline: -10.8%Key Issue: Increased competition in financial services and payment processing is impacting earnings outlooks.12. FMC (FMC-US)Target Price (Mar 12, 2025): $49Target Price (Jan 17, 2025): $67Decline: -26.9%Key Issue: Weak demand for agricultural chemicals and rising input costs are pressuring earnings expectations.13. Huntington Ingalls Industries (HII-US)Target Price (Mar 12, 2025): $199Target Price (Jan 17, 2025): $224Decline: -11.2%Key Issue: Changes in defense and shipbuilding budgets, along with reductions in government spending, have weighed on earnings projections.14. Hewlett Packard Enterprise (HPE-US)Target Price (Mar 12, 2025): $20Target Price (Jan 17, 2025): $24Decline: -16.7%Key Issue: Slowing demand for enterprise IT infrastructure and increased competition in the cloud computing market are affecting the company’s growth prospects.15. Kraft Heinz (KHC-US)Target Price (Mar 12, 2025): $32Target Price (Jan 17, 2025): $36Decline: -11.1%Key Issue: Rising raw material costs and changing consumer spending habits highlight the need for brand competitiveness improvements.16. Microchip Technology (MCHP-US)Target Price (Mar 12, 2025): $66Target Price (Jan 17, 2025): $80Decline: -17.5%Key Issue: Short-term uncertainties in the semiconductor industry and inventory adjustments are negatively impacting earnings expectations.17. Mondelez International Class A (MDLZ-US)Target Price (Mar 12, 2025): $67Target Price (Jan 17, 2025): $75Decline: -10.7%Key Issue: Slowing global consumer goods market growth and rising raw material costs are increasing margin pressures.18. MarketAxess Holdings (MKTX-US)Target Price (Mar 12, 2025): $232Target Price (Jan 17, 2025): $259Decline: -10.4%Key Issue: Increased competition in the bond trading platform market and interest rate volatility are affecting revenue growth.19. Moderna (MRNA-US)Target Price (Mar 12, 2025): $53Target Price (Jan 17, 2025): $69Decline: -23.2%Key Issue: Declining COVID-19 vaccine demand and uncertainties in new drug development are impacting investor sentiment.20. NetApp (NTAP-US)Target Price (Mar 12, 2025): $123Target Price (Jan 17, 2025): $138Decline: -10.9%Key Issue: Increased competition in the data storage and cloud solutions market is slowing the company’s growth trajectory.21. ON Semiconductor (ON-US)Target Price (Mar 12, 2025): $61Target Price (Jan 17, 2025): $79Decline: -22.8%Key Issue: Strong demand for automotive semiconductors is offset by weak IT and consumer electronics demand, leading to lower revenue forecasts.22. Sempra (SRE-US)Target Price (Mar 12, 2025): $83Target Price (Jan 17, 2025): $94Decline: -11.7%Key Issue: Market volatility in the energy and utilities sector and changing regulatory environments are weighing on profitability forecasts.23. Skyworks Solutions (SWKS-US)Target Price (Mar 12, 2025): $72Target Price (Jan 17, 2025): $97Decline: -25.8%Key Issue: Weakening demand for 5G components and increasing competition in the smartphone market are negatively impacting growth.24. Teleflex (TFX-US)Target Price (Mar 12, 2025): $165Target Price (Jan 17, 2025): $240Decline: -31.3%Key Issue: Slowing demand in the medical device market and global economic uncertainty are lowering earnings projections.25. United Parcel Service Class B (UPS-US)Target Price (Mar 12, 2025): $131Target Price (Jan 17, 2025): $148Decline: -11.5%Key Issue: Slowing growth in the global logistics market and rising costs are putting pressure on profit margins.26. Western Digital (WDC-US)Target Price (Mar 12, 2025): $79Target Price (Jan 17, 2025): $88Decline: -10.2%Key Issue: Short-term weakness in the memory semiconductor market and declining prices are impacting revenue and profitability.27. West Pharmaceutical Services (WST-US)Target Price (Mar 12, 2025): $281Target Price (Jan 17, 2025): $377Decline: -25.5%Key Issue: Rising raw material costs and increasing competition in the pharmaceutical and medical device industries are pressuring growth expectations.While the reasons and extent of target price downgrades vary by company, overall, these revisions reflect common macroeconomic risks, such as economic recession fears, supply chain uncertainties, rising costs, intensifying competition.Additionally, some companies are affected by structural industry changes, such as fluctuations in EV battery demand and semiconductor industry trends.From a sell-side perspective, stocks experiencing significant target price cuts could face short-term downside pressure. Investors should consider risk management strategies, including portfolio rebalancing, short positions, market-driven adjustments – Stay alert to upcoming earnings reports, interest rate changes, and key economic indicators, as these can significantly impact volatility.By aligning investment decisions with broader market trends, investors can navigate these shifts with greater flexibility and strategic foresight.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.
article
Strong Sell
Strong Sell
AMD
Advanced Micro Devices
+26